Published in Br J Haematol on June 01, 2007
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA (2011) 3.16
Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes. Blood (2009) 1.21
Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB. PLoS Genet (2013) 1.08
Clinical significance of microRNAs in chronic and acute human leukemia. Mol Cancer (2016) 0.99
miR deregulation in CLL. Adv Exp Med Biol (2013) 0.79
The role of TP53 network in the pathogenesis of chronic lymphocytic leukemia. Int J Clin Exp Pathol (2013) 0.77
Role of microRNA in chronic lymphocytic leukemia onset and progression. J Hematol Oncol (2015) 0.76
Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum (2002) 2.58
Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma. Br J Haematol (2006) 2.09
Molecular basis of mantle cell lymphoma. Br J Haematol (2004) 1.23
Gene expression changes in a zebrafish model of drug dependency suggest conservation of neuro-adaptation pathways. J Exp Biol (2008) 1.20
Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder. Lancet (2003) 1.13
Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood (2002) 1.08
Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia. Oncogene (2003) 1.05
Microarray transcript profiling distinguishes the transient from the acute type of megakaryoblastic leukaemia (M7) in Down's syndrome, revealing PRAME as a specific discriminating marker. Br J Haematol (2004) 1.02
Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells. Blood (2004) 1.01
Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML. Blood (2011) 0.95
GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death. Blood (2010) 0.95
Cutaneous cryptococcosis in Hodgkin lymphoma. Br J Haematol (2013) 0.94
Identification of a potential role for POU2AF1 and BTG4 in the deletion of 11q23 in chronic lymphocytic leukemia. Genes Chromosomes Cancer (2005) 0.92
Altered gene expression patterns in intrauterine growth restriction: potential role of hypoxia. Am J Obstet Gynecol (2007) 0.87
PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism. Leuk Res (2002) 0.83
In vitro and in vivo downregulation of MRP1 by antisense oligonucleotides: a potential role in neuroblastoma therapy. Int J Cancer (2002) 0.82
Transchromosomic cell model of Down syndrome shows aberrant migration, adhesion and proteome response to extracellular matrix. Proteome Sci (2009) 0.81
Emerging therapy for chronic lymphocytic leukaemia. Br J Haematol (2007) 0.79
Trinucleotide repeat dynamic mutation identifying susceptibility in familial and sporadic chronic lymphocytic leukaemia. Br J Haematol (2006) 0.78
Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research. Br J Haematol (2004) 0.78
Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftment. Br J Haematol (2002) 0.77
Genetic alterations underlying the pathogenesis of MALT lymphoma. Hematol J (2002) 0.77
New alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposide-induced apoptosis. Apoptosis (2007) 0.77
Independent clones at separable stages of differentiation, bearing different GATA1 mutations, in the same TMD patient with Down syndrome. Blood (2005) 0.75
A defining moment for hairy cell leukaemia. Br J Haematol (2011) 0.75
The importance of developing world haematology. Br J Haematol (2011) 0.75
Mantle cell lymphoma: new treatments targeted to the biology. Clin Lymphoma (2002) 0.75
Multipotential cord blood cells. Are they the future? Br J Haematol (2009) 0.75
Cell death in leukemia: passenger protein regulation by topoisomerase inhibitors. Biochem Biophys Res Commun (2007) 0.75